OCI 7 - 2004
Premarket Notification [510(k)] Summary
(per 21 CFR 807.92)

1. Submitted by: K o% at 3 a

Diamond Age Systems, Inc. —~

3775 South Laurel Way

Chandler, AZ 85249

Phone: (866) 546-5444

Contact Person: Geoffrey D. Swank

Vice-President of Laser Operations

Phone: (303) 263-3307

Fax: (303) 985-7957

Date Prepared: 29 August 2004
2. Device Name
Trade/Proprietary Name: Azuryt Model CTL 1401, CO2 Surgical Laser System
Common/Usual Name: General Surgical Laser System
Classification Name: Laser Instrument, Surgical, Powered

(per 21 CFR 878.4810)

3. Predicate Device:
The Azuryt Model CTL 1401, COz2 Surgical Laser System is substantially
equivalent to other laser systems on the market, such as the Deka Smart CO2
laser, cleared under K031224 and K031440; and the Lumenis LX-20 CO2
Surgical Laser System, cleared under K896478, K953074, and K960475.
4. Intended use of the device
The Azuryt Model CTL 1401, CO2 Surgical Laser System is indicated for the
incision, excision, ablation, vaporization and coagulation of body soft tissues,
including intraoral tissues. These systems can be used in a variety of medical
specialties, including general and plastic surgery, dentistry, oral/maxillofacial
surgery, dermatology, gastroenterology, gynecology, otorhinolaryngology,
aesthetical surgery, neurosurgery, oculoplastic, orthopedic, pulmonary/thoracic
surgery, and urology.

5. Description of the Device
The, Azuryt Model CTL 1401 CO2 Surgical Laser System is a COz laser
consisting of a power supply, cooling system, laser head, articulated arm,
handpiece, microcomputer and control panel.
6. Summary of the technological characteristics of the device
compared to the predicate device.
Like the predicate devices, the Azuryt Mode! CTL 1401 is a CO2 surgical laser
system, utilizing a laser with a wavelength of 10.6 um. Each of these devices
contains a power supply, a cooling system, a sealed COz laser head delivering a
beam with a wavelength of 10.6 ym, an arm to deliver the laser beam, a
handpiece and a variety of accessories to address specific surgical needs.
7. Testing
The manufacturer of the Azuryt Model CTL 1401certifies that its device complies
with the following international! standards:
EN60825-1, IEC 60825-1, Safety of laser products — Part 1: Equipment
classification, requirements and user's guide.
EN60601-2-22, IEC 60601-2-22, Medical Electrical Equipment — Part 2:
Particular requirements for the safety of diagnostic and therapeutic laser
equipment.
EN60601-1, IEC 60601-1, Medical Electrical Equipment — Part 1: General
requirements for safety, as amended by amendment 1 (1991) and
amendment 2 (1995).
EN60601-1-2, IEC 60601-1-2, Medical Electrical Equipment — Part 1:
General requirements for safety — 2. Collateral Standard:
Electromagnetic compatibility - Requirements and tests
The device also complies with the European Medical Device Directive 92/42/EEC
and the US Federal Performance Standards 21 CFR 1040.10 and 21 CFR
1040.11 for Class IV Laser Products, except for deviations pursuant to Laser
Notice No. 50, dated 26 July 2001.
8. Conclusions
Based upon the testing and comparison to the predicate devices, the Azuryt
Model CTL 1401 has the same intended uses, with similar technological
characteristics as the predicate devices. The system performs as intended and
raises no new safety or effectiveness issues.

“rea
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
BMC
“ne Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Diamond Age Systems, Inc. acl 7 - 2004
c/o Mr. Ned E. Devine
Entela, Inc.
3033 Madison Avenue, SE
Grand Rapids, Michigan 49548
Re: K042439
Trade/Device Name: Azuryt Model CTL 1401, CO2 Surgical Laser System
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: September 21, 2004
Received: September 22,2004 Dear Mr. Devine:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class IJ] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Ned Devine
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Ald, q 7

Celia M. Witten, Ph.D., M.D.

Director

Division of General, Restorative

and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): K042439
Device Name: Azuryt Model CTL 1401, CO> Surgical Laser System
/ Indications For Use:
The Azuryt Model CTL 1401, CO2 Surgical Laser System is indicated for the
incision, excision, ablation, vaporization and coagulation of body soft tissues,
including intraoral tissues. These systems can be used in a variety of medical
specialties, including general and plastic surgery, dentistry, oral/maxillofacial
surgery, dermatology, gastroenterology, gynecology, otorhinolaryngology,
aesthetical surgery, neurosurgery, oculoplastic, orthopedic, pulmonary/thoracic
surgery, and urology.
Prescription Use__X ANDIOR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
f (Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
Ko4a43t Page | of |
510(k) Namber___+ a

